# Dmed secures monthly production capacity of 3 million syringe-type medical devices

Dmed, a bio-convergence medical device company, has secured automated production facilities capable of producing up to 3 million syringe-type medical devices per month at its Dmed Innovation Tower in Seongnam, South Korea. The company has started mass production of about 40 types of medical devices and plans total investment of 82 billion won by 2029.

- Type: Expansion
- Announced: 2026-11-06
- Where: Seongnam, Gyeonggi Province, South Korea, South Korea
- Value: $60.0M (82.0B KRW)
- Starts operating: Oct 2026
- Status: completed
- Capacity: 3 million units per month
- Products: syringe-type medical devices, tissue repair biomaterials, collagen-based medical materials, bio-convergence medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Dmed](https://endata.com/companies/16242.md)

## Sources

- [yakup.com](https://www.yakup.com/news/index.html?mode=view&nid=334874), 2026-11-06: "디메드가 확보한 월 최대 300만 개 시린지형 의료기기 생산능력은 모두 자체 개발 제품의 양산에 활용되고 있다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.